Bill & Melinda Gates Foundation

Vanderbilt scientist Houra Merrikh led a team of researchers who discovered the first evolution-resistant chemical compound that prevents drug resistance development in bacteria. The compound is also a drug development platform that targets antimicrobial resistance during treatment of infections with antibiotics and evolution in general, Merrikh said. Read More

Vanderbilt engineers have developed a new method for duplicating DNA that makes devices small enough to hold in your hand that are capable of identifying infectious agents before symptoms appear. Read More

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine. Read More

An important predictor of the severity of respiratory syncytial virus (RSV) in infants may be what their mothers ate during pregnancy. Read More

Using a SmartPhone platform and a $100,000 grant from Grand Challenges Explorations, an initiative of the Bill & Melinda Gates Foundation, Vanderbilt Pediatric Surgeon John Pietsch, M.D., and fourth-year medical student Katherine Allen may revolutionize the way infants and children all over the world are assessed and treated for proper nutrition. Read More

Vanderbilt researchers are using a variety of approaches to hasten the beginning of the end of malaria. Read More